Table of contents:
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Technology
6.1 Protein and Nucleic acid isolation
6.2 Chromatography
6.3 Gel Electrophoresis
6.4 Mass Spectrometry
6.5 High Throughput Screening
6.6 Protein Microarrays
6.7 DNA Microarrays
6.8 QPCR
6.9 Others
Chapter 7 Market Segmentation, By Service
7.1 Biological Services
7.2 Chemical Services
7.3 Pharmaceutical Services
7.4 Drug Metabolism and Pharmacokinetics (DMPK) Services
Chapter 8 Market Segmentation, By End Users
8.1 Biopharmaceuticals
8.2 Biotech companies
8.3 Pharmaceutical companies
8.4 Research Institutes
8.5 Others
Chapter 9 Market Segmentation, By Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
9.2 Europe
9.2.1 Introduction
9.2.2 U.K
9.2.3 Spain
9.2.4 Italy
9.2.5 France
9.2.6 Russia
9.2.7 Others
9.3 Asia-Pacific
9.3.1 Introduction
9.3.2 China
9.3.3 India
9.3.4 Japan
9.3.5 Australia
9.3.6 Others
9.4 South America
9.4.1 Introduction
9.4.2 Brazil
9.4.3 Argentina
9.4.4 Others
9.5 The Middle East & Africa
9.5.1 Introduction
9.5.2 South Africa
9.5.3 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1. Roche Holding AG
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2. Merck & Co. Inc
11.3. Eli Lily
11.4. GlaxoSmithKline LLC
11.5. Pfizer, Inc
11.6. AstraZeneca PLc
11.7. Johnson and Johnson
11.8. Sanofi
11.9. Jubilant Biosys
11.10. Bayer AG
11.11. Covance
11.12. Boehringer Ingelheim GmBh
11.13. Albany Molecular Research Inc.
11.14. Charles River Laboratories
11.15. Infosys
Chapter 12 Market Estimates and Forecast
12.1 Market Estimates and Forecast 2018-2024(USD Million)
12.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecast by Service 2018-2024 (USD Million)
12.1.3 Market Estimation and Forecast by End Users 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
